8 results on '"Lane, Andrew H."'
Search Results
2. Juvenile Granulosa Cell Tumor Mimicking HAIR-AN in a 4-yearold: A Case Report.
- Author
-
Choe Kim, Rachel, Goldberg, Ilya, Van Brunt, Trevor, Tul-Bushra, Hamama, Batiste, Rebecca, Lane, Andrew H., and Hsieh, Helen
- Subjects
- *
TESTOSTERONE , *SEX hormones , *PROGESTERONE , *PHYSICAL diagnosis , *HYPERTRICHOSIS , *PELVIS , *SALPINGO-oophorectomy , *GRANULOSA cell tumors , *HYPERANDROGENISM , *COMPUTED tomography , *HYPERINSULINISM , *POLYCYSTIC ovary syndrome , *TREATMENT effectiveness , *LACTATE dehydrogenase , *INSULIN resistance , *HEMOCHROMATOSIS , *CLINICAL pathology , *MELANOSIS , *HEALTH care teams , *SYMPTOMS , *CHILDREN - Abstract
Predominantly androgen secreting juvenile granulosa cell tumors (JGCT) are uncommon and few reports have been published. We present a case of a JGCT that presented with signs of prepubertal hyperandrogenism and insulin resistance to highlight the possible interaction between hyperandrogenemia and hyperinsulinism. A 4-year-old girl presented with acanthosis nigricans and hyperinsulinism, mimicking the hyperandrogenism, insulin resistance and acanthosis nigricans syndrome at an age much younger than is typical for this diagnosis. Laboratory studies revealed elevated insulin, inhibin A and B, and total testosterone. All laboratory results normalized after unilateral salpingo-oophorectomy. The final diagnosis was Stage 1A JGCT. This case highlights the importance of including ovarian tumors in the differential diagnosis when considering causes of virilization and insulin resistance. This case also suggests a potential relationship between excess testosterone secretion and hyperinsulinemia and strengthens evidence that hyperandrogenemia may promote hyperinsulinism in ovarian disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Accuracy of self-reported height measurements in parents and its effect on mid-parental target height calculation.
- Author
-
Braziuniene, Ieva, Wilson, Thomas A., and Lane, Andrew H.
- Subjects
- *
STATURE , *MEASUREMENT , *PARENTS , *PEDIATRIC endocrinology , *CHILDREN - Abstract
Background: Clinical determination of mid-parental height is an important part of the assessment of a child's growth, however our clinical impression has been that parents cannot be relied upon to accurately report their own heights. Therefore, we conducted this study to assess the accuracy of parental height self-reporting and its effect on calculated mid-parental target height for children presenting to a pediatric endocrinology office. Methods: All parents bringing their children for an initial evaluation to a pediatric endocrinology clinic over a period of nine months were questioned and then measured by a pediatric endocrinologist. Parents were blinded to the study. Mid-parental target heights, based on reported and actual height were compared. Results: There were 241 families: 98 fathers and 217 mothers in our study. Mean measured paternal height was 173.2 cm, self reported 174.9 cm (p < 0.0001), partner reported 177 cm (p = 0.0004). Only 50% of fathers and 58% of mothers reported their height within ± 2 cm of their measured height, while 15% of fathers and 12% of mothers were inaccurate by more than 4 cm. Mean measured maternal height was 160.6 cm, self-reported 161.1 cm (NS), partner reported 161.7 cm (NS). Inaccuracy of height self-report had a small but significant effect on the mean MPTH (0.4 cm, p = 0.045). Analysis showed that only 70% of MPTH calculated by reported heights fell within ± 2 cm of MPTH calculated using measured heights, 24% being in ± 2-4 cm range, and 6% were inaccurate by more than 4 cm. Conclusion: There is a significant difference in paternal measured versus reported heights with an overall trend for fathers to overestimate their own height. A large subset of parents makes a substantial error in their height self-report, which leads to erroneous MPTH. Inaccuracy is even greater when one parent reports the other parent's height. When a child's growth is in question, measured rather than reported parental heights should be obtained. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
4. Type 1 Diabetes Mellitus Masked by Primary Adrenal Insufficiency in a Child with Autoimmune Polyglandular Syndrome Type 2.
- Author
-
Aijaz, Naghma J., Blanco, Ernesto, Lane, Andrew H., and Wilson, Thomas A.
- Subjects
- *
JUVENILE diseases , *DIABETES in children , *ENDOCRINE diseases , *AUTOIMMUNE diseases - Abstract
Describes a case of a pediatric patient with hyperthyroidism who later presented simultaneously with adrenal insufficiency and diabetes mellitus. Medical history of the patient; Diagnosis of autoimmune polyglandular syndrome type 2 (APS2); Characteristics of APS2; Mode of therapy.
- Published
- 2003
- Full Text
- View/download PDF
5. The Effect of Oral Leucine on Protein Metabolism in Adolescents with Type 1 Diabetes Mellitus.
- Author
-
Desikan, Vardhini, Mileva, Izolda, Garlick, Jeremy, Lane, Andrew H., Wilson, Thomas A., and McNurlan, Margaret A.
- Subjects
- *
LEUCINE , *PROTEIN metabolism , *PEOPLE with diabetes , *INSULIN , *AMINO acids - Abstract
Lack of insulin results in a catabolic state in subjects with insulin-dependent diabetes mellitus which is reversed by insulin treatment. Amino acid supply, especially branched chain amino acids such as leucine, enhances protein synthesis in both animal and human studies. This small study was undertaken to assess the acute effect of supplemental leucine on protein metabolism in adolescents with type 1 diabetes. L-[1-13C] Leucine was used to assess whole-body protein metabolism in six adolescent females (16-18 yrs) with type 1 diabetes during consumption of a basal diet (containing 58 μmoles leucine/kg/h) and the basal diet with supplemental leucine (232 μmoles leucine/kg/h). Net leucine balance was significantly higher with supplemental leucine (56.33 ± 12.13 μmoles leucine/kg body weight/hr) than with the basal diet (−11.7 ± −5.91, P < .001) due to reduced protein degradation (49.54 ± 18.80 μmoles leucine/kg body weight/hr) compared to the basal diet (109 ± 13.05, P < .001). [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
6. Neurocognitive function in children with compensated hypothyroidism: lack of short term effects on or off thyroxin.
- Author
-
Aijaz, Naghma J., Flaherty, Evelyn M., Preston, Thomas, Storch Bracken, Stacey, Lane, Andrew H., and Wilson, Thomas A.
- Subjects
- *
THYROID diseases , *HYPOTHYROIDISM in children , *THYROXINE , *NEUROPSYCHOLOGY , *HYPOTHYROIDISM treatment , *THERAPEUTICS - Abstract
Background: Although thyroxin therapy clearly is beneficial to children with frank hypothyroidism there is little data on the effects of thyroxin in children with compensated or subclinical hypothyroidism. The objective of this study was to determine the effect of thyroxin therapy on cognitive function in children with compensated hypothyroidism. The hypothesis was that thyroxin therapy would change neuropsychological function. Methods: Eleven patients with a history of sub clinical hypothyroidism entered the study. At the start of the study, six out of the 11 were on thyroxin therapy, while 5 were off therapy. All patients underwent a battery of neuropsychological testing and thyroid function tests at the start of study. Based on the results of thyroid function tests, two of the 5 patients who were off thyroxin were started back on thyroxin. All of the 6 patients who were on thyroxin were taken off thyroxin. All patients then underwent repeat neuropsychological testing and thyroid functions after an average of 91 days. Results: Thyroxin therapy could not be shown to have an effect on neuropsychological function in this short term study. Our patients had attention problems as compared to the normal population. No significant differences were found between our subjects and normal population standards in verbal processing, visual processing, motor speed/coordination and achievement. Conclusion: In this small, short term study, thyroxin therapy could not be shown to affect neuropsychological function in children with compensated hypothyroidism. These children may have attention problems but appear to have normal verbal and visual processing, motor speed/coordination and achievement. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
7. Mutations in CEP57 cause mosaic variegated aneuploidy syndrome.
- Author
-
Snape, Katie, Hanks, Sandra, Ruark, Elise, Barros-Núñez, Patricio, Elliott, Anna, Murray, Anne, Lane, Andrew H., Shannon, Nora, Callier, Patrick, Chitayat, David, Clayton-Smith, Jill, FitzPatrick, David R, Gisselsson, David, Jacquemont, Sebastien, Asakura-Hay, Keiko, Micale, Mark A., Tolmie, John, Turnpenny, Peter D., Wright, Michael, and Douglas, Jenny
- Subjects
- *
GENETIC mutation , *ANEUPLOIDY , *CENTROSOMES , *MICROTUBULES , *CELL division - Abstract
Using exome sequencing and a variant prioritization strategy that focuses on loss-of-function variants, we identified biallelic, loss-of-function CEP57 mutations as a cause of constitutional mosaic aneuploidies. CEP57 is a centrosomal protein and is involved in nucleating and stabilizing microtubules. Our findings indicate that these and/or additional functions of CEP57 are crucial for maintaining correct chromosomal number during cell division. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
8. Common Pathogenetic Mechanism for Three Tumor Types in Bilateral Acoustic Neurofibromatosis.
- Author
-
SEIZINGER, BERND R., ROULEAU, GUY, OZELIUS, LAURIE J., LANE, ANDREW H., ST. GEORGE-HYSLOP, PETER, HUSON, SUSAN, GUSELLA, JAMES F., and MARTUZA, ROBERT L.
- Abstract
Bilateral acoustic neurofibromatosis (BANF) is a genetic defect associated with multiple tumors ofneural crest origin. Specific loss ofalleles from chromosome 22 was detected with polymorphic DNA markers in two acoustic neuromas, two neurofibromas, and one meningioma from BANF patients. This indicates a common pathogenetic mechanism for all three tumor types. The two neurofibromas were among three taken from the same patient, and both showed loss ofidentical alleles demonstrating that the same chromosome suffered deletion in both tumors. The third neurofibroma from this patient showed no detectable loss ofheterozygosity, which suggests the possibility ofa more subtle mutational event that affects chromosome 22. In the two acoustic neuromas, only a portion of chromosome 22 was deleted, narrowing the possible chromosomal location ofthe gene that causes BANF to the region distal to the D22S9 locus in band 22q11. The identification of progressively smaller deletions on chromosome 22 in these tumor types may well provide a means to clone and characterize the defect. [ABSTRACT FROM AUTHOR]
- Published
- 1987
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.